Soleno Therapeutics
SLNO
#4360
Rank
A$3.09 B
Marketcap
$71.79
Share price
-0.39%
Change (1 day)
21.99%
Change (1 year)

Soleno Therapeutics (SLNO) - Cash on Hand

Cash on Hand as of September 2024 : A$0.41 Billion

According to Soleno Therapeutics's latest financial reports the company has A$0.41 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Soleno Therapeutics - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$0.24 B1060.68%
2022-12-31A$21.45 M-26.98%
2021-12-31A$29.38 M-54.1%
2020-12-31A$64.01 M116.18%
2019-12-31A$29.61 M-13.36%
2018-12-31A$34.17 M56.04%
2017-12-31A$21.9 M479.18%
2016-12-31A$3.78 M-49.86%
2015-12-31A$7.54 M-22.42%
2014-12-31A$9.72 M583.51%
2013-12-31A$1.42 M-31.42%
2012-12-31A$2.07 M